287 related articles for article (PubMed ID: 7539383)
1. Comparison of the inhibitory effect of AcSDKP, TNF-alpha, TGF-beta, and MIP-1 alpha on marrow-purified CD34+ progenitors.
Bonnet D; Lemoine FM; Najman A; Guigon M
Exp Hematol; 1995 Jun; 23(6):551-6. PubMed ID: 7539383
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression.
Broxmeyer HE; Sherry B; Cooper S; Lu L; Maze R; Beckmann MP; Cerami A; Ralph P
J Immunol; 1993 Apr; 150(8 Pt 1):3448-58. PubMed ID: 7682242
[TBL] [Abstract][Full Text] [Related]
4. The growth response of Lin-Thy-1+ hematopoietic progenitors to cytokines is determined by the balance between synergy of multiple stimulators and negative cooperation of multiple inhibitors.
Jacobsen SE; Ruscetti FW; Ortiz M; Gooya JM; Keller JR
Exp Hematol; 1994 Sep; 22(10):985-9. PubMed ID: 7522186
[TBL] [Abstract][Full Text] [Related]
5. Macrophage inflammatory protein (MIP)-1 beta abrogates the capacity of MIP-1 alpha to suppress myeloid progenitor cell growth.
Broxmeyer HE; Sherry B; Cooper S; Ruscetti FW; Williams DE; Arosio P; Kwon BS; Cerami A
J Immunol; 1991 Oct; 147(8):2586-94. PubMed ID: 1918979
[TBL] [Abstract][Full Text] [Related]
6. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.
Reid CD; Stackpoole A; Meager A; Tikerpae J
J Immunol; 1992 Oct; 149(8):2681-8. PubMed ID: 1383322
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-11 (IL-11) and IL-9 counteract the inhibitory activity of transforming growth factor beta 3 (TGF-beta 3) on human primitive hematopoietic progenitor cells.
Lemoli RM; Fogli M; Fortuna A; Tura S
Haematologica; 1995; 80(1):5-12. PubMed ID: 7758992
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
9. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.
Santiago-Schwarz F; Rappa DA; Laky K; Carsons SE
Stem Cells; 1995 Mar; 13(2):186-97. PubMed ID: 7540472
[TBL] [Abstract][Full Text] [Related]
10. Contrasting effects of rh-MIP-1 alpha and TGF-beta 1 on chronic myeloid leukemia progenitors in vitro.
Holyoake TL; Freshney MG; Sproul AM; Richmond LJ; Alcorn MJ; Steward WP; Fitzsimons E; Dunlop DJ; Franklin IM; Pragnell IB
Stem Cells; 1993 Oct; 11 Suppl 3():122-8. PubMed ID: 8298472
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta 1 enhances the suppression of human hematopoiesis by tumor necrosis factor-alpha or recombinant interferon-alpha.
Sing GK; Keller JR; Ellingsworth LR; Ruscetti FW
J Cell Biochem; 1989 Feb; 39(2):107-15. PubMed ID: 2715197
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta regulates the cell cycle status of interleukin-3 (IL-3) plus IL-1, stem cell factor, or IL-6 stimulated CD34+ human hematopoietic progenitor cells through different cell kinetic mechanisms depending on the applied stimulus.
Lardon F; Snoeck HW; Nijs G; Lenjou M; Peetermans ME; Rodrigus I; Berneman ZN; Van Bockstaele DR
Exp Hematol; 1994 Aug; 22(9):903-9. PubMed ID: 7520393
[TBL] [Abstract][Full Text] [Related]
13. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood.
Strife A; Lambek C; Perez A; Darzynkiewicz Z; Skierski J; Gulati S; Haley JD; ten Dijke P; Iwata KK; Clarkson BD
Cancer Res; 1991 Sep; 51(18):4828-36. PubMed ID: 1893375
[TBL] [Abstract][Full Text] [Related]
14. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
15. Production of hematopoietic regulatory cytokines by peripheral blood mononuclear cells in patients with aplastic anemia.
Hsu HC; Tsai WH; Chen LY; Hsu ML; Ing-Tiau Kuo B; Ho CH; Lin CK; Wang SY
Exp Hematol; 1996 Jan; 24(1):31-6. PubMed ID: 8536789
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta and MIP-1 alpha exert their main inhibitory activity on very primitive CD34+2CD38- cells but show opposite effects on more mature CD34+CD38+ human hematopoietic progenitors.
Van Ranst PC; Snoeck HW; Lardon F; Lenjou M; Nijs G; Weekx SF; Rodrigus I; Berneman ZN; Van Bockstaele DR
Exp Hematol; 1996 Nov; 24(13):1509-15. PubMed ID: 8950234
[TBL] [Abstract][Full Text] [Related]
17. Reversible inhibitory effects and absence of toxicity of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in human long-term bone marrow culture.
Bonnet D; Lemoine FM; Khoury E; Pradelles P; Najman A; Guigon M
Exp Hematol; 1992 Nov; 20(10):1165-9. PubMed ID: 1385195
[TBL] [Abstract][Full Text] [Related]
18. Special susceptibility to apoptosis of CD1a+ dendritic cell precursors differentiating from cord blood CD34+ progenitors.
Canque B; Camus S; Yagello M; Gluckman JC
Stem Cells; 1998; 16(3):218-28. PubMed ID: 9617897
[TBL] [Abstract][Full Text] [Related]
19. Activity of acetyl-n-ser-asp-lys-pro (AcSDKP) on hematopoietic progenitor cells in short-term and long-term murine bone marrow cultures.
Jackson JD; Yan Y; Ewel C; Talmadge JE
Exp Hematol; 1996 Feb; 24(3):475-81. PubMed ID: 8599978
[TBL] [Abstract][Full Text] [Related]
20. Synergism of interleukin 12, interleukin 3 and serum factor on primitive human hematopoietic progenitor cells.
Hirao A; Takaue Y; Kawano Y; Sato J; Suzue T; Abe T; Saito S; Kawahito M; Okamoto Y; Makimoto A
Stem Cells; 1995 Jan; 13(1):47-53. PubMed ID: 7536512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
